85 related articles for article (PubMed ID: 22928442)
1. [The anaplastic thyroid carcinoma research consortium of Japan].
Sugitani I
Nihon Geka Gakkai Zasshi; 2012 Jul; 113(4):368-72. PubMed ID: 22928442
[TBL] [Abstract][Full Text] [Related]
2. Management of Anaplastic Thyroid Carcinoma: the Fruits from the ATC Research Consortium of Japan.
Sugitani I; Onoda N; Ito KI; Suzuki S
J Nippon Med Sch; 2018; 85(1):18-27. PubMed ID: 29540641
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.
Sugitani I; Miyauchi A; Sugino K; Okamoto T; Yoshida A; Suzuki S
World J Surg; 2012 Jun; 36(6):1247-54. PubMed ID: 22311136
[TBL] [Abstract][Full Text] [Related]
4. Super-radical surgery for anaplastic thyroid carcinoma: a large cohort study using the Anaplastic Thyroid Carcinoma Research Consortium of Japan database.
Sugitani I; Hasegawa Y; Sugasawa M; Tori M; Higashiyama T; Miyazaki M; Hosoi H; Orita Y; Kitano H
Head Neck; 2014 Mar; 36(3):328-33. PubMed ID: 23729360
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Heikkilä A; Heiskanen I; Arola J; Haglund C
Oncology; 2010; 79(5-6):400-8. PubMed ID: 21455012
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches.
Are C; Shaha AR
Ann Surg Oncol; 2006 Apr; 13(4):453-64. PubMed ID: 16474910
[TBL] [Abstract][Full Text] [Related]
7. Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2).
Onoda N; Sugitani I; Higashiyama T; Hara H; Ito K; Kammori M; Sugino K; Suzuki S; Toda K; Yoshida A; Miyauchi A
BMC Cancer; 2015 Jun; 15():475. PubMed ID: 26091846
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic thyroid carcinoma: a 50-year experience at a single institution.
McIver B; Hay ID; Giuffrida DF; Dvorak CE; Grant CS; Thompson GB; van Heerden JA; Goellner JR
Surgery; 2001 Dec; 130(6):1028-34. PubMed ID: 11742333
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors.
Kebebew E; Greenspan FS; Clark OH; Woeber KA; McMillan A
Cancer; 2005 Apr; 103(7):1330-5. PubMed ID: 15739211
[TBL] [Abstract][Full Text] [Related]
10. Anaplastic thyroid carcinoma in ecuador: analysis of prognostic factors.
Pacheco-Ojeda LA; Martínez AL; Alvarez M
Int Surg; 2001; 86(2):117-21. PubMed ID: 11918236
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors of anaplastic thyroid carcinoma.
Kihara M; Miyauchi A; Yamauchi A; Yokomise H
Surg Today; 2004; 34(5):394-8. PubMed ID: 15108075
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic thyroid carcinoma: a case of a young women that reports a survival exceeding 6 years.
Batori M; Chatelou E; Straniero A; Ruggieri M
Eur Rev Med Pharmacol Sci; 2007; 11(1):69-71. PubMed ID: 17405351
[TBL] [Abstract][Full Text] [Related]
13. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy.
Yau T; Lo CY; Epstein RJ; Lam AK; Wan KY; Lang BH
Ann Surg Oncol; 2008 Sep; 15(9):2500-5. PubMed ID: 18581185
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid.
Sugitani I; Kasai N; Fujimoto Y; Yanagisawa A
World J Surg; 2001 May; 25(5):617-22. PubMed ID: 11369989
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategies in the management of patients with metastatic anaplastic thyroid cancer: review of the current literature.
Granata R; Locati L; Licitra L
Curr Opin Oncol; 2013 May; 25(3):224-8. PubMed ID: 23493194
[TBL] [Abstract][Full Text] [Related]
17. Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines.
Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
Oncol Rep; 2007 Sep; 18(3):715-20. PubMed ID: 17671725
[TBL] [Abstract][Full Text] [Related]
18. Aberrant l1 cell adhesion molecule affects tumor behavior and chemosensitivity in anaplastic thyroid carcinoma.
Kim KS; Min JK; Liang ZL; Lee K; Lee JU; Bae KH; Lee MH; Lee SE; Ryu MJ; Kim SJ; Kim YK; Choi MJ; Jo YS; Kim JM; Shong M
Clin Cancer Res; 2012 Jun; 18(11):3071-8. PubMed ID: 22472175
[TBL] [Abstract][Full Text] [Related]
19. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
[TBL] [Abstract][Full Text] [Related]
20. [Anaplastic carcinoma of the thyroid: diagnosis and treatment].
Giuffrida D; Lavenia G; Aiello RA; Di Blasi C; Gambera G; Pappalardo A; Petralia G; Ursino M; Failla G
Clin Ter; 2001; 152(4):255-61. PubMed ID: 11725619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]